Neurogene (NGNE) Change in Receivables (2013 - 2015)
Neurogene (NGNE) reported Change in Receivables of $12000.0 for Q4 2015, up 209.09% on a YoY basis from $3882.4 in Q4 2014, and up 122.64% quarter-over-quarter from -$53000.0 in Q3 2015.
Neurogene (NGNE) Change in Receivables (2013 - 2015) Analysis & Trends
Neurogene has reported Change in Receivables for 3 years, with the latest figure at $12000.0 in Q4 2015.
- For the quarter ending Q4 2015, Change in Receivables rose 209.09% year-over-year to $12000.0; the trailing twelve-month figure through Dec 2015 stood at -$34000.0 (down 189.83% YoY), and the FY2015 full-year result was -$34000.0, down 191.89% from the prior year.
- Change in Receivables for Q4 2015 stood at $12000.0, up from -$53000.0 in the prior quarter.
- The five-year high for Change in Receivables was $43000.0 in Q3 2014, with the low at -$53000.0 in Q3 2015.
- Historically, Change in Receivables has averaged $270.83 across 3 years, with a median of -$2988.0 in 2013.
- The largest YoY upside for Change in Receivables was 22841.18% in 2014 against a maximum downside of 358.06% in 2014.
- Neurogene's Change in Receivables stood at -$6146.0 in 2013, then plunged by 78.98% to -$11000.0 in 2014, then surged by 209.09% to $12000.0 in 2015.
- The last three Change in Receivables figures came in at $12000.0 (Q4 2015), -$53000.0 (Q3 2015), and $15000.0 (Q2 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 12,000.00 |
| Dec 31, 2015 | 12,000.00 |
| Sep 30, 2015 | -53,000.00 |
| Sep 30, 2015 | -53,000.00 |
| Jun 30, 2015 | 15,000.00 |
| Jun 30, 2015 | 15,000.00 |
| Mar 31, 2015 | -8,000.00 |
| Mar 31, 2015 | -8,000.00 |
| Dec 31, 2014 | -11,000.00 |
| Dec 31, 2014 | -11,000.00 |
| Sep 30, 2014 | 43,000.00 |
| Sep 30, 2014 | 43,000.00 |
| Jun 30, 2014 | -33,151.00 |
| Jun 30, 2014 | -33,151.00 |
| Mar 31, 2014 | 39,000.00 |
| Mar 31, 2014 | 39,000.00 |
| Dec 31, 2013 | -6,146.00 |
| Dec 31, 2013 | -6,146.00 |
| Sep 30, 2013 | -7,469.00 |
| Sep 30, 2013 | -7,469.00 |